A CBD treatment for epilepsy is closer to becoming the first cannabis medicine approved for the U.S. market.
The panel voted unanimously to recommend that the FDA approve Epidiolex after hearing presentations on the drug’s effectiveness and safety.
The recommendation doesn’t bind the agency to approving Epidiolex, but its recommendations carry serious weight.
The FDA has said it will issue a decision by late June.
(Click here to read the full story at Hemp Industry Daily.)